Target intelligence / Profile preview

Preferentially expressed antigen in melanoma pseudogene

Molecular classification
Pseudogene
01

Overview

Preferentially expressed antigen in melanoma pseudogene (ENSG00000231590) is a genomic sequence in humans that closely resembles the protein-coding PRAME gene but does not encode a functional protein. Pseudogenes typically arise following gene duplications or retrotransposition events and are considered nonfunctional due to mutations, lack of regulatory elements, or incomplete sequence. There is no evidence that this pseudogene is expressed, codes for a protein, or has a direct biological or disease role. Its existence is of potential interest for genomic evolution or bioinformatics, but not for drug development, biomarker applications, or basic biology at this time.

Beyond the preview

Go deeper on Preferentially expressed antigen in melanoma pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Preferentially expressed antigen in melanoma pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call